Laura Agresta is an Assistant Professor in the Department of Pediatrics and Human Development within the College of Human Medicine. Her research focuses on translating genetically-informed, precision therapies into clinical research trials for children and adolescents with cancer.
Dr. Agresta received her M.D. from Michigan State University and her M.S. in Pharmacology from the University of Cincinnati. She completed her residency in pediatrics at Children’s Hospital of Pittsburgh and her fellowship in pediatric hematology/oncology at Cincinnati Children’s Hospital. Prior to coming to MSU, she was a Fellow in Precision Cancer Therapeutics, Clinical Pharmacology & Predictive Medicine at Cincinnati Children's.
Dr. Agresta collaborates with laboratory scientists, physicians, and pharmacists to identify promising drug candidates and develop clinical trials that safely study new drugs in pediatric patients. She is also interested in using pharmacokinetic modeling to optimize drug efficacy and minimize toxicity on an individual patient level. She hopes that continued, highly-collaborative research in pediatric precision oncology will one day provide every patient with a safe and curative therapy.